Literature DB >> 21339919

The role of B-type and other natriuretic peptides in health and disease.

Ashok Krishnaswami.   

Abstract

Natriuretic peptide (NP) physiology is a complex field. NPs also are known to be highly phylogenetically preserved. NPs can be thought of as counterregulatory hormones antagonizing the effects of the renin-angiotensin-aldosterone and sympathetic systems. These peptides are primarily responsible for maintaining salt and water homeostasis, but they also have vasodilatory properties. It was originally thought that B-type NP (BNP) and N-terminal-pro-BNP are secreted in a 1:1 ratio. However, recent data has shed further light into this area. Commercial assays for NPs will need to keep up with these changes. Currently, BNP levels within Kaiser Permanente are obtained by multiple providers in a variety of clinical scenarios in order to help them manage their patients. Therefore, a basic understanding of the physiology of NPs and the methodology of assays are needed to appropriately interpret an NP test result within the corresponding clinical scenario.

Entities:  

Year:  2008        PMID: 21339919      PMCID: PMC3037138          DOI: 10.7812/TPP/08-019

Source DB:  PubMed          Journal:  Perm J        ISSN: 1552-5767


  32 in total

Review 1.  BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases.

Authors:  Marc A Silver; Alan Maisel; Clyde W Yancy; Peter A McCullough; John C Burnett; Gary S Francis; Mandeep R Mehra; William Franklin Peacock; Gregg Fonarow; W Brian Gibler; David A Morrow; Judd Hollander
Journal:  Congest Heart Fail       Date:  2004 Sep-Oct

2.  Transcardiac gradients of N-terminal B-type natriuretic peptide in aortic valve stenosis.

Authors:  Markku Kupari; Heikki Turto; Jyri Lommi; Markku Mäkijärvi; Hannu Parikka
Journal:  Eur J Heart Fail       Date:  2005-08       Impact factor: 15.534

3.  Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide.

Authors:  Marc S Sabatine; David A Morrow; James A de Lemos; C Michael Gibson; Sabina A Murphy; Nader Rifai; Carolyn McCabe; Elliott M Antman; Christopher P Cannon; Eugene Braunwald
Journal:  Circulation       Date:  2002-04-16       Impact factor: 29.690

4.  Comparison of B-type natriuretic peptide levels in patients with heart failure with versus without mitral regurgitation.

Authors:  Susan A Mayer; James A De Lemos; Sabina A Murphy; Sandra Brooks; Brad J Roberts; Paul A Grayburn
Journal:  Am J Cardiol       Date:  2004-04-15       Impact factor: 2.778

Review 5.  Natriuretic peptides and acute renal failure.

Authors:  David L Vesely
Journal:  Am J Physiol Renal Physiol       Date:  2003-08

6.  Usefulness of an elevated B-type natriuretic peptide to predict allograft failure, cardiac allograft vasculopathy, and survival after heart transplantation.

Authors:  Mandeep R Mehra; Patricia A Uber; Srinivasa Potluri; Hector O Ventura; Robert L Scott; Myung H Park
Journal:  Am J Cardiol       Date:  2004-08-15       Impact factor: 2.778

7.  Plasma concentrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects, cardiac transplant recipients and patients with dialysis-independent or dialysis-dependent chronic renal failure.

Authors:  M G Buckley; D Sethi; N D Markandu; G A Sagnella; D R Singer; G A MacGregor
Journal:  Clin Sci (Lond)       Date:  1992-10       Impact factor: 6.124

8.  Design, synthesis, and actions of a novel chimeric natriuretic peptide: CD-NP.

Authors:  Ondrej Lisy; Brenda K Huntley; Daniel J McCormick; Paul A Kurlansky; John C Burnett
Journal:  J Am Coll Cardiol       Date:  2008-07-01       Impact factor: 24.094

9.  Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea.

Authors:  Christian Mueller; André Scholer; Kirsten Laule-Kilian; Benedict Martina; Christian Schindler; Peter Buser; Matthias Pfisterer; André P Perruchoud
Journal:  N Engl J Med       Date:  2004-02-12       Impact factor: 91.245

10.  Correlation of the myocardial performance index with plasma B-type natriuretic peptide levels in patients with mitral regurgitation.

Authors:  Nurten Sayar; A Lütfullah Orhan; Nazmiye Cakmak; Hale Yilmaz; Hüsnü Atmaca; Burak Tangürek; Hakan Hasdemir; Zekeriya Nurkalem; Mehmet Ergelen; Hale Aksu; Kemal Yeşilçimen
Journal:  Int J Cardiovasc Imaging       Date:  2007-05-31       Impact factor: 2.357

View more
  2 in total

1.  Preliminary Development of a DNA Aptamer-Magnetic Bead Capture Electrochemiluminescence Sandwich Assay for Brain Natriuretic Peptide.

Authors:  John G Bruno; Alicia M Richarte; Taylor Phillips
Journal:  Microchem J       Date:  2014-07-01       Impact factor: 4.821

Review 2.  B-Type Natriuretic Peptide (BNP) Revisited-Is BNP Still a Biomarker for Heart Failure in the Angiotensin Receptor/Neprilysin Inhibitor Era?

Authors:  Toshio Nishikimi; Yasuaki Nakagawa
Journal:  Biology (Basel)       Date:  2022-07-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.